Mechanisms of Modafinil: A Review of Current Research

Overview

Journal Neuropsychiatr Dis Treat

Publisher Dove Medical Press

Specialty Psychiatry

Date 2009 Mar 21

PMID 19300566

Citations 60

Authors

Paul Gerrard

Robert Malcolm

Affiliations

Soon will be listed here.

Abstract

The novel wake-promoting agent modafinil has been in use for the treatment of several sleep disorders for a few years and is now undergoing clinical trials for its use in the treatment of stimulant addiction, but its primary mechanism of action remains elusive. Previous laboratory studies have shown that modafinil has antioxidative and neuroprotective effects, which have not previously been suggested to be related to its wake-promoting effects. However, recent research indicates that free radicals may be related to sleep induction as well as cellular damage, suggesting that a common target of action may mediate modafinil's ability to oppose both of these effects. In this review we summarize and discuss previously published research on modafinil's neural, cytoprotective, and cognitive effects, and we propose possible primary biochemical targets that could underlie the effects of modafinil observed in these studies. We also suggest neurocognitive mechanisms responsible for modafinil's cognitive enhancing effects and its therapeutic potential in the treatment of stimulant addiction.

Citing Articles

TAK-861, a potent, orally available orexin receptor 2-selective agonist, produces wakefulness in monkeys and improves narcolepsy-like phenotypes in mouse models.

Mitsukawa K, Terada M, Yamada R, Monjo T, Hiyoshi T, Nakakariya M Sci Rep. 2024; 14(1):20838.

PMID: 39242684 PMC: 11379823. DOI: 10.1038/s41598-024-70594-1.

Pharmacological Treatments for Methamphetamine Use Disorder: Current Status and Future Targets.

Yates J Subst Abuse Rehabil. 2024; 15:125-161.

PMID: 39228432 PMC: 11370775. DOI: 10.2147/SAR.S431273.

Restoring consciousness with pharmacologic therapy: Mechanisms, targets, and future directions.

Barra M, Solt K, Yu X, Edlow B Neurotherapeutics. 2024; 21(4):e00374.

PMID: 39019729 PMC: 11452330. DOI: 10.1016/j.neurot.2024.e00374.

Post-stroke fatigue: a review of development, prevalence, predisposing factors, measurements, and treatments.

Chen W, Jiang T, Huang H, Zeng J Front Neurol. 2024; 14:1298915.

PMID: 38187145 PMC: 10768193. DOI: 10.3389/fneur.2023.1298915.

Neurological Insights into Sleep Disorders in Parkinson's Disease.

Thangaleela S, Sivamaruthi B, Kesika P, Mariappan S, Rashmi S, Choeisoongnern T Brain Sci. 2023; 13(8).

PMID: 37626558 PMC: 10452387. DOI: 10.3390/brainsci13081202.

References

Klimesch W . EEG alpha and theta oscillations reflect cognitive and memory performance: a review and analysis. Brain Res Brain Res Rev. 1999; 29(2-3):169-95. DOI: 10.1016/s0165-0173(98)00056-3. View

Perez de la Mora M, Aguilar-Garcia A, Ramirez-Ramirez R, Mendez-Franco J, Rambert F, Fuxe K . Effects of the vigilance promoting drug modafinil on the synthesis of GABA and glutamate in slices of rat hypothalamus. Neurosci Lett. 1999; 259(3):181-5. DOI: 10.1016/s0304-3940(98)00905-7. View

Stone E, Cotecchia S, Lin Y, Quartermain D . Role of brain alpha 1B-adrenoceptors in modafinil-induced behavioral activity. Synapse. 2002; 46(4):269-70. DOI: 10.1002/syn.10127. View

Della Marca G, Restuccia D, Rubino M, Maiese T, Tonali P . Influence of modafinil on somatosensory input processing in the human brain-stem. Clin Neurophysiol. 2004; 115(4):919-26. DOI: 10.1016/j.clinph.2003.11.003. View

Ellis C, Monk C, Simmons A, Lemmens G, Williams S, Brammer M . Functional magnetic resonance imaging neuroactivation studies in normal subjects and subjects with the narcoleptic syndrome. Actions of modafinil. J Sleep Res. 1999; 8(2):85-93. DOI: 10.1046/j.1365-2869.1999.00142.x. View

Madras B, Xie Z, Lin Z, Jassen A, Panas H, Lynch L . Modafinil occupies dopamine and norepinephrine transporters in vivo and modulates the transporters and trace amine activity in vitro. J Pharmacol Exp Ther. 2006; 319(2):561-9. DOI: 10.1124/jpet.106.106583. View

Robertson P, Decory H, Madan A, Parkinson A . In vitro inhibition and induction of human hepatic cytochrome P450 enzymes by modafinil. Drug Metab Dispos. 2000; 28(6):664-71. View

Ballon J, Feifel D . A systematic review of modafinil: Potential clinical uses and mechanisms of action. J Clin Psychiatry. 2006; 67(4):554-66. DOI: 10.4088/jcp.v67n0406. View

Cantero J, Atienza M, Salas R . State-modulation of cortico-cortical connections underlying normal EEG alpha variants. Physiol Behav. 2001; 71(1-2):107-15. DOI: 10.1016/s0031-9384(00)00334-6. View

10.

Killgore W, McBride S, Killgore D, Balkin T . The effects of caffeine, dextroamphetamine, and modafinil on humor appreciation during sleep deprivation. Sleep. 2006; 29(6):841-7. DOI: 10.1093/sleep/29.6.841. View

11.

Xiao Y, Fu J, Dong Z, Yang J, Zeng F, Zhu L . Neuroprotective mechanism of modafinil on Parkinson disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Acta Pharmacol Sin. 2004; 25(3):301-5. View

12.

Ferraro L, Fuxe K, Tanganelli S, Fernandez M, Rambert F, Antonelli T . Amplification of cortical serotonin release: a further neurochemical action of the vigilance-promoting drug modafinil. Neuropharmacology. 2000; 39(11):1974-83. DOI: 10.1016/s0028-3908(00)00019-8. View

13.

Klose T, Blaisdell J, Goldstein J . Gene structure of CYP2C8 and extrahepatic distribution of the human CYP2Cs. J Biochem Mol Toxicol. 1999; 13(6):289-95. DOI: 10.1002/(sici)1099-0461(1999)13:6<289::aid-jbt1>3.0.co;2-n. View

14.

Jones B . From waking to sleeping: neuronal and chemical substrates. Trends Pharmacol Sci. 2005; 26(11):578-86. DOI: 10.1016/j.tips.2005.09.009. View

15.

Gervasini G, Martinez C, Agundez J, Benitez J . Inhibition of cytochrome P450 2C9 activity in vitro by 5-hydroxytryptamine and adrenaline. Pharmacogenetics. 2001; 11(1):29-37. DOI: 10.1097/00008571-200102000-00004. View

16.

Antonelli T, Ferraro L, Hillion J, Tomasini M, Rambert F, Fuxe K . Modafinil prevents glutamate cytotoxicity in cultured cortical neurons. Neuroreport. 1999; 9(18):4209-13. DOI: 10.1097/00001756-199812210-00038. View

17.

Sevy S, Rosenthal M, Alvir J, Meyer S, Visweswaraiah H, Gunduz-Bruce H . Double-blind, placebo-controlled study of modafinil for fatigue and cognition in schizophrenia patients treated with psychotropic medications. J Clin Psychiatry. 2005; 66(7):839-43. DOI: 10.4088/jcp.v66n0705. View

18.

Liley D, Alexander D, Wright J, Aldous M . Alpha rhythm emerges from large-scale networks of realistically coupled multicompartmental model cortical neurons. Network. 1999; 10(1):79-92. View

19.

Uftring S, Wachtel S, Chu D, McCandless C, Levin D, de Wit H . An fMRI study of the effect of amphetamine on brain activity. Neuropsychopharmacology. 2001; 25(6):925-35. DOI: 10.1016/S0893-133X(01)00311-6. View

20.

Avshalumov M, Chen B, Koos T, Tepper J, Rice M . Endogenous hydrogen peroxide regulates the excitability of midbrain dopamine neurons via ATP-sensitive potassium channels. J Neurosci. 2005; 25(17):4222-31. PMC: 6725114. DOI: 10.1523/JNEUROSCI.4701-04.2005. View